NCT04541082 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04541082
Title	Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Jazz Pharmaceuticals
Indications	atypical teratoid rhabdoid tumor gliomatosis cerebri pilocytic astrocytoma high grade ependymoma central nervous system sarcoma medulloblastoma choroid plexus cancer pleomorphic xanthoastrocytoma gliosarcoma high grade glioma central nervous system cancer anaplastic astrocytoma fibrillary astrocytoma pineal gland cancer neuroectodermal tumor oligodendroglioma meningioma
Therapies	ONC206
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
National Institutes of Health	RECRUITING	Bethesda	Maryland	20892	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04541082Clinical Trial Detail